CJ215 showed excellent uptake in a variety of tumor models in vivo, representing some of the most prevalent cancers including breast (4T1), prostate (PC3-PSMA), fibrosarcoma (HT1080) and colon (CT26), Fig 1 G. This evidence concerns the gene FOLH1 and fibrosarcoma.